SlideShare une entreprise Scribd logo
1  sur  24
EVALUATION OF ACCELERATED-CXL* AFTER 
IONTOPHORESIS 
FOR THE TREATMENT OF MELTING KERATITIS 
IN 6 CATS 
* Collagen Cross-Linking 
Dr Frank FAMOSE – Toulouse - France 
Pierre ROY – Paris - France 
London 2014
Melting keratitis 
MMP imbalance 
High perforation risk 
Treatment : antibiotics 
& anticollagenases 
Tectonic Surgery 
CXL
CXL 
Photochemical 
process 
Collagen reticulation 
Anti-infectious effects 
Keratocyte apoptosis
CXL: protocol modifications 
Epithelium RF distribution UVA irradiation
Iontophoresis 
Application of a constant electric 
current to enhance penetration 
of a ionized substance through a 
tissue
Aim of this study 
To evaluate the clinical outcome 
of feline melting keratitis 
treated by accelerated CXL 
after iontophoresis of riboflavin
Inclusion criteria 
Cats 
Corneal melting 
Poor response to 
medical treatment
Inclusion criteria 
Epithelial loss 
Cellular infiltration and 
stromal dissolution 
Minimal Corneal thickness 
> 300 μm (OCT)
Protocol 
General 
anesthesia 
Corneal 
cleaning 
Riboflavine 
impregnation 
Exposition 
UVA 365 nm 
Post-CXL 
treatment 
OCT 
Medetomidine 
Ketamine 
Debris removal 
Bact. sampling 
PCR (FHV1) 
RF 0,1% (Ricrolin TM) 
Iontophoresis 
5 min 1mA/min 
30 mW/cm² 
3 min 
5,4J/cm² 
TobrexTM BID 
7 days 
Accelerated protocol 
(KXLTM – Avedro)
Iontophoresis 
device
Follow-up 
Inclusion D1 D4 D8 D15 D31 
Pain and clinical score 
Ulceration and infiltration surfaces
Follow-up 
0 : absent 
1 : light 
2 : moderate 
3 : severe 
0 : absent 
1 : present 
Clinical score 
(0-18) 
Pain score 
(0-7) 
Mucopurulent discharge 
Corneal edema 
Corneal vascularization 
Conjunctivitis 
Blepharitis 
Uveitis 
Prostration 
Aggressive behavior 
Blepharospasm 
Enophtalmos 
Photophobia 
Ocular pruritus 
Defense reaction
Results Mean evolution time 
40 days 
Ulcer depth 21-54% 
2/6 Persian 
1/6 positive bacterial 
culture 
1/6 FHV1 positive 6 cats
12 
10 
8 
6 
4 
2 
0 
Evolution of 
Average scores 
D1 D4 D8 D15 D31 
Clinical score Pain score 
35 
30 
25 
20 
15 
10 
5 
0 
Evolution of 
Average surfaces (mm²) 
D1 D4 D8 D15 D31 
Ulcer surface Infiltration surface
Corneal 
vascularization
Discussion : efficacy 
Reduction of clinical 
and pain score 
Complete Epithelial 
healing 
Resolution of corneal melting
Comparison to conventional 
impregnation of RF
Distribution of RF ? 
Clear cornea Keratitis 
Human and rabbit studies 
(fluorometry, histology, 
HPLC, OCT…) 
Anterior stroma (150 μm) : 
Cinstillation= 2x Ciontophoresis 
Less uniform diffusion 
?
Adverse effects of iontophoresis 
Electric burns 
High intensity current 
Chemical burns High or low pH solutions 
Not observed in human 
patients with I < 4mA/min 
Pain
Duration of treatment ? 
Instillation 
30 min 
Iontophoresis 
5 min 
Irradiation 
30 min 
Accelerated CXL 
3-10 min 
Conventional protocol 
Duration > 1 hour 
Ionto + acc. CXL protocol 
Duration < 20 min.
Conclusion: IONTOPHORESIS 
Resolution of corneal melting 
Results similar to 
conventional instillation 
No adverse reaction or pain 
Reduction of 
procedure duration
Perspectives: IONTOPHORESIS 
Enhanced penetration of RF… 
…or other therapeutic agents 
?
Thank you.

Contenu connexe

Tendances

Dr. Edmision - November 14th
Dr. Edmision - November 14thDr. Edmision - November 14th
Dr. Edmision - November 14th
FocusOttawa
 
Early Complications After Penetrating Keratoplasty
Early Complications After Penetrating KeratoplastyEarly Complications After Penetrating Keratoplasty
Early Complications After Penetrating Keratoplasty
Moulaye Haidara, MD
 

Tendances (20)

Dr. Edmision - November 14th
Dr. Edmision - November 14thDr. Edmision - November 14th
Dr. Edmision - November 14th
 
The recent updates about corneal collagen crosslinking
The recent updates about corneal collagen crosslinkingThe recent updates about corneal collagen crosslinking
The recent updates about corneal collagen crosslinking
 
Trans epithelial versus epithelium-off corneal cross-linking for the treatment
Trans epithelial versus epithelium-off corneal cross-linking for the treatmentTrans epithelial versus epithelium-off corneal cross-linking for the treatment
Trans epithelial versus epithelium-off corneal cross-linking for the treatment
 
Keratoplasty associated complications
Keratoplasty associated complicationsKeratoplasty associated complications
Keratoplasty associated complications
 
Collagen Cross Linking
Collagen Cross LinkingCollagen Cross Linking
Collagen Cross Linking
 
Higher fluence, irradiation profiles, epi on slideshare
Higher fluence, irradiation profiles, epi on slideshareHigher fluence, irradiation profiles, epi on slideshare
Higher fluence, irradiation profiles, epi on slideshare
 
Inflammatory markers in tears & CXL
Inflammatory markers in tears &  CXLInflammatory markers in tears &  CXL
Inflammatory markers in tears & CXL
 
Pseudophakic Bullous Keratopathy case
Pseudophakic Bullous Keratopathy case Pseudophakic Bullous Keratopathy case
Pseudophakic Bullous Keratopathy case
 
Postoperative complication of penetrating keratoplasty
Postoperative complication of penetrating keratoplastyPostoperative complication of penetrating keratoplasty
Postoperative complication of penetrating keratoplasty
 
Cxl
CxlCxl
Cxl
 
Keratoplasty
KeratoplastyKeratoplasty
Keratoplasty
 
One way to optimize Corneal Cross linking (CXL) !!
One way to optimize Corneal Cross linking (CXL) !!  One way to optimize Corneal Cross linking (CXL) !!
One way to optimize Corneal Cross linking (CXL) !!
 
INDICATIONS OF KERATOPLASTY (Bindu K M)
INDICATIONS OF KERATOPLASTY (Bindu K M)INDICATIONS OF KERATOPLASTY (Bindu K M)
INDICATIONS OF KERATOPLASTY (Bindu K M)
 
Keratoplasty
Keratoplasty Keratoplasty
Keratoplasty
 
Keratoplasty update 2016
Keratoplasty update 2016Keratoplasty update 2016
Keratoplasty update 2016
 
Early Complications After Penetrating Keratoplasty
Early Complications After Penetrating KeratoplastyEarly Complications After Penetrating Keratoplasty
Early Complications After Penetrating Keratoplasty
 
keratoprosthesis
keratoprosthesiskeratoprosthesis
keratoprosthesis
 
Corneal cross linking with new beam profile
Corneal cross linking with new beam profileCorneal cross linking with new beam profile
Corneal cross linking with new beam profile
 
Avedro Barraquer S E O\'11
Avedro  Barraquer  S E O\'11Avedro  Barraquer  S E O\'11
Avedro Barraquer S E O\'11
 
Keratoplasty
KeratoplastyKeratoplasty
Keratoplasty
 

En vedette

En vedette (13)

Cxl for the treatment of bullous keratopathy in dogs
Cxl for the treatment of bullous keratopathy in dogsCxl for the treatment of bullous keratopathy in dogs
Cxl for the treatment of bullous keratopathy in dogs
 
Ulceres cornee lt_afvac_2014_ff
Ulceres cornee lt_afvac_2014_ffUlceres cornee lt_afvac_2014_ff
Ulceres cornee lt_afvac_2014_ff
 
Ponction chambre anterieure_afvac_2014_ff
Ponction chambre anterieure_afvac_2014_ffPonction chambre anterieure_afvac_2014_ff
Ponction chambre anterieure_afvac_2014_ff
 
Pigmentation irienne afvac 2014_ff
Pigmentation irienne afvac 2014_ffPigmentation irienne afvac 2014_ff
Pigmentation irienne afvac 2014_ff
 
Ulceres cornee ct_afvac_2014_ff
Ulceres cornee ct_afvac_2014_ffUlceres cornee ct_afvac_2014_ff
Ulceres cornee ct_afvac_2014_ff
 
Ionto sferov 2014
Ionto sferov 2014Ionto sferov 2014
Ionto sferov 2014
 
Verisome (TM) a New Injectable Sustained Release and Biodegradable Intraocula...
Verisome (TM) a New Injectable Sustained Release and Biodegradable Intraocula...Verisome (TM) a New Injectable Sustained Release and Biodegradable Intraocula...
Verisome (TM) a New Injectable Sustained Release and Biodegradable Intraocula...
 
Iontophoresis wireless application
Iontophoresis wireless applicationIontophoresis wireless application
Iontophoresis wireless application
 
iontophoresis
iontophoresisiontophoresis
iontophoresis
 
Ocdds vaibhav katare
Ocdds  vaibhav katareOcdds  vaibhav katare
Ocdds vaibhav katare
 
Iontophoresis
Iontophoresis Iontophoresis
Iontophoresis
 
Iontophoresis brito.
Iontophoresis brito.Iontophoresis brito.
Iontophoresis brito.
 
Vesicular Dosage Forms - Evaluation of vesicular dosage forms
Vesicular Dosage Forms - Evaluation of vesicular dosage formsVesicular Dosage Forms - Evaluation of vesicular dosage forms
Vesicular Dosage Forms - Evaluation of vesicular dosage forms
 

Similaire à Cross linking-iontophoresis-cats famose-ecvo_v2

Cross linking dogs_cats_famose_ecvo
Cross linking dogs_cats_famose_ecvoCross linking dogs_cats_famose_ecvo
Cross linking dogs_cats_famose_ecvo
Frank FAMOSE
 
Intense pulsed light therapy in onychomycosis l dr m
Intense pulsed light therapy  in onychomycosis l   dr  mIntense pulsed light therapy  in onychomycosis l   dr  m
Intense pulsed light therapy in onychomycosis l dr m
Laterna
 

Similaire à Cross linking-iontophoresis-cats famose-ecvo_v2 (20)

Cross linking dogs_cats_famose_ecvo
Cross linking dogs_cats_famose_ecvoCross linking dogs_cats_famose_ecvo
Cross linking dogs_cats_famose_ecvo
 
Primary cutaneous lymphoma
Primary cutaneous lymphoma  Primary cutaneous lymphoma
Primary cutaneous lymphoma
 
Evaluation of accelerated collagen cross-linking for the treatment of melting...
Evaluation of accelerated collagen cross-linking for the treatment of melting...Evaluation of accelerated collagen cross-linking for the treatment of melting...
Evaluation of accelerated collagen cross-linking for the treatment of melting...
 
Diabetic Macular Edema
Diabetic Macular EdemaDiabetic Macular Edema
Diabetic Macular Edema
 
Ocular surface squamous neoplasiaa.ppt1
Ocular surface squamous neoplasiaa.ppt1Ocular surface squamous neoplasiaa.ppt1
Ocular surface squamous neoplasiaa.ppt1
 
Oral Cancer
Oral CancerOral Cancer
Oral Cancer
 
Corneal edema after cataract surgery - MALEK AL KOTT
Corneal edema after cataract surgery - MALEK AL KOTTCorneal edema after cataract surgery - MALEK AL KOTT
Corneal edema after cataract surgery - MALEK AL KOTT
 
Approach to a case of corneal ulcer
Approach to a case of corneal ulcerApproach to a case of corneal ulcer
Approach to a case of corneal ulcer
 
Superior limbic keratoconjunctivitis
Superior limbic keratoconjunctivitisSuperior limbic keratoconjunctivitis
Superior limbic keratoconjunctivitis
 
Fungal keratitis
Fungal keratitisFungal keratitis
Fungal keratitis
 
Management of chronic rhinitis
Management of chronic rhinitisManagement of chronic rhinitis
Management of chronic rhinitis
 
Sw sn
Sw snSw sn
Sw sn
 
Achilles tendinopathy treatment with triple therapy
Achilles tendinopathy treatment with triple therapyAchilles tendinopathy treatment with triple therapy
Achilles tendinopathy treatment with triple therapy
 
photodynamic therapy
photodynamic therapyphotodynamic therapy
photodynamic therapy
 
Alma 2016 Clinical Publication - Legato II Treats Scars
Alma 2016 Clinical Publication - Legato II Treats Scars Alma 2016 Clinical Publication - Legato II Treats Scars
Alma 2016 Clinical Publication - Legato II Treats Scars
 
Nepafenac 0.1% in macular thickness in patients who had undergone cataract su...
Nepafenac 0.1% in macular thickness in patients who had undergone cataract su...Nepafenac 0.1% in macular thickness in patients who had undergone cataract su...
Nepafenac 0.1% in macular thickness in patients who had undergone cataract su...
 
Photodynamic therapy in treatment of oral lichen planus: Dr Aparna
Photodynamic therapy in treatment of oral lichen planus: Dr AparnaPhotodynamic therapy in treatment of oral lichen planus: Dr Aparna
Photodynamic therapy in treatment of oral lichen planus: Dr Aparna
 
Intense pulsed light therapy in onychomycosis l dr m
Intense pulsed light therapy  in onychomycosis l   dr  mIntense pulsed light therapy  in onychomycosis l   dr  m
Intense pulsed light therapy in onychomycosis l dr m
 
( )Anal scc
( )Anal scc( )Anal scc
( )Anal scc
 
Aetiology and management of acute kidney injury in
Aetiology and management of acute kidney injury inAetiology and management of acute kidney injury in
Aetiology and management of acute kidney injury in
 

Plus de Frank FAMOSE

Plus de Frank FAMOSE (17)

Entropion du Sharpei _ QDC_ PratiqueVet
Entropion du Sharpei _ QDC_ PratiqueVetEntropion du Sharpei _ QDC_ PratiqueVet
Entropion du Sharpei _ QDC_ PratiqueVet
 
L'entropion du Sharpei_QDC_PratiqueVet
L'entropion du Sharpei_QDC_PratiqueVetL'entropion du Sharpei_QDC_PratiqueVet
L'entropion du Sharpei_QDC_PratiqueVet
 
Oct sferov-2014
Oct sferov-2014Oct sferov-2014
Oct sferov-2014
 
Tonometrie glaucome - en pratique - Frank FAMOSE
Tonometrie glaucome - en pratique - Frank FAMOSETonometrie glaucome - en pratique - Frank FAMOSE
Tonometrie glaucome - en pratique - Frank FAMOSE
 
Procidence de la membrane nictitante - Frank FAMOSE
Procidence de la membrane nictitante - Frank FAMOSEProcidence de la membrane nictitante - Frank FAMOSE
Procidence de la membrane nictitante - Frank FAMOSE
 
Le musée des horreurs
Le musée des horreursLe musée des horreurs
Le musée des horreurs
 
Sémiologie iris
Sémiologie irisSémiologie iris
Sémiologie iris
 
Cancérologie oculaire chez les carnivores
Cancérologie oculaire chez les carnivoresCancérologie oculaire chez les carnivores
Cancérologie oculaire chez les carnivores
 
Diagnostic des uvéites chez les carnivores
Diagnostic des uvéites chez les carnivoresDiagnostic des uvéites chez les carnivores
Diagnostic des uvéites chez les carnivores
 
Cataracte diabétique chez les carnivores
Cataracte diabétique chez les carnivoresCataracte diabétique chez les carnivores
Cataracte diabétique chez les carnivores
 
Particularités du glaucome chez le chat
Particularités du glaucome chez le chatParticularités du glaucome chez le chat
Particularités du glaucome chez le chat
 
Sauvegarder la vue_frank_famose
Sauvegarder la vue_frank_famoseSauvegarder la vue_frank_famose
Sauvegarder la vue_frank_famose
 
Sauvegarder la vue_ Frank FAMOSE
Sauvegarder la vue_ Frank FAMOSESauvegarder la vue_ Frank FAMOSE
Sauvegarder la vue_ Frank FAMOSE
 
Cataracte sclerose
Cataracte scleroseCataracte sclerose
Cataracte sclerose
 
Eyetrackn°1
Eyetrackn°1Eyetrackn°1
Eyetrackn°1
 
Cécité brutale chez un chat
Cécité brutale chez un chatCécité brutale chez un chat
Cécité brutale chez un chat
 
Poster-FF-OCT-Birmingham-WSAVA
Poster-FF-OCT-Birmingham-WSAVAPoster-FF-OCT-Birmingham-WSAVA
Poster-FF-OCT-Birmingham-WSAVA
 

Cross linking-iontophoresis-cats famose-ecvo_v2

  • 1. EVALUATION OF ACCELERATED-CXL* AFTER IONTOPHORESIS FOR THE TREATMENT OF MELTING KERATITIS IN 6 CATS * Collagen Cross-Linking Dr Frank FAMOSE – Toulouse - France Pierre ROY – Paris - France London 2014
  • 2. Melting keratitis MMP imbalance High perforation risk Treatment : antibiotics & anticollagenases Tectonic Surgery CXL
  • 3. CXL Photochemical process Collagen reticulation Anti-infectious effects Keratocyte apoptosis
  • 4. CXL: protocol modifications Epithelium RF distribution UVA irradiation
  • 5. Iontophoresis Application of a constant electric current to enhance penetration of a ionized substance through a tissue
  • 6. Aim of this study To evaluate the clinical outcome of feline melting keratitis treated by accelerated CXL after iontophoresis of riboflavin
  • 7. Inclusion criteria Cats Corneal melting Poor response to medical treatment
  • 8. Inclusion criteria Epithelial loss Cellular infiltration and stromal dissolution Minimal Corneal thickness > 300 μm (OCT)
  • 9. Protocol General anesthesia Corneal cleaning Riboflavine impregnation Exposition UVA 365 nm Post-CXL treatment OCT Medetomidine Ketamine Debris removal Bact. sampling PCR (FHV1) RF 0,1% (Ricrolin TM) Iontophoresis 5 min 1mA/min 30 mW/cm² 3 min 5,4J/cm² TobrexTM BID 7 days Accelerated protocol (KXLTM – Avedro)
  • 11. Follow-up Inclusion D1 D4 D8 D15 D31 Pain and clinical score Ulceration and infiltration surfaces
  • 12. Follow-up 0 : absent 1 : light 2 : moderate 3 : severe 0 : absent 1 : present Clinical score (0-18) Pain score (0-7) Mucopurulent discharge Corneal edema Corneal vascularization Conjunctivitis Blepharitis Uveitis Prostration Aggressive behavior Blepharospasm Enophtalmos Photophobia Ocular pruritus Defense reaction
  • 13. Results Mean evolution time 40 days Ulcer depth 21-54% 2/6 Persian 1/6 positive bacterial culture 1/6 FHV1 positive 6 cats
  • 14. 12 10 8 6 4 2 0 Evolution of Average scores D1 D4 D8 D15 D31 Clinical score Pain score 35 30 25 20 15 10 5 0 Evolution of Average surfaces (mm²) D1 D4 D8 D15 D31 Ulcer surface Infiltration surface
  • 16. Discussion : efficacy Reduction of clinical and pain score Complete Epithelial healing Resolution of corneal melting
  • 17. Comparison to conventional impregnation of RF
  • 18.
  • 19. Distribution of RF ? Clear cornea Keratitis Human and rabbit studies (fluorometry, histology, HPLC, OCT…) Anterior stroma (150 μm) : Cinstillation= 2x Ciontophoresis Less uniform diffusion ?
  • 20. Adverse effects of iontophoresis Electric burns High intensity current Chemical burns High or low pH solutions Not observed in human patients with I < 4mA/min Pain
  • 21. Duration of treatment ? Instillation 30 min Iontophoresis 5 min Irradiation 30 min Accelerated CXL 3-10 min Conventional protocol Duration > 1 hour Ionto + acc. CXL protocol Duration < 20 min.
  • 22. Conclusion: IONTOPHORESIS Resolution of corneal melting Results similar to conventional instillation No adverse reaction or pain Reduction of procedure duration
  • 23. Perspectives: IONTOPHORESIS Enhanced penetration of RF… …or other therapeutic agents ?

Notes de l'éditeur

  1. Good afternood Ladies and Gentlemen, before talking about iontophoresis and its application to corneal cross-linking, I’d like to thank the ECVO comitee for allowing me to present these results.
  2. As you know, melting keratitis is a serious condition which is considered as an ocular emergency due to the high risk or corneal perforation. The melting of the cornea is due to metalloproteinase imbalance in relation with infectious or not infectious conditions. When the medical treatment, based on antibiotics and anticollagenases doesn’t succeed, surgery is indicated for tectonic purposes. Corneal collagen cross-linking is used for the treatment of infectious or melting keratitis in humans for some years and more recently for dogs, cats and horses.
  3. To remind you with the technical aspects of collagen cross-linking, this process is a photochemical reaction between free radicals generated by the activation of riboflavin by UVA light and the fibrils of corneal collagen. This photoactivation leads to collagen reticulation responsible for the improvement of the mechanical strength and resistance to enzymatic digestion of the stroma, direct antiinfectious effects and a modulation of inflammatory corneal response via keratocyte apoptosis. The process is divided in two parts : -impregnation of the stroma by riboflavin - Irradiation by UVA.
  4. Collagen cross-linking has been primarily developed for the treatment of human progressive keratoconus and all the protocols used are adapted from the conventional protocol. This consists in instillation of riboflavin during 30 minutes after removal of the epithelium and UV exposition for 30 minutes à 3 mW/cm². Modifications of this protocol have been proposed for 3 aims : preserving the epithelium, enhancing the riboflavin impregnation or shortening the exposition time by increasing the UV light intensity. Iontophoresis is a way of enhancing riboflavin impregnation.
  5. The principle of iontophoresis is to increase the penetration of a ionized substance through a tissue by the application of a constant electric current. It has been used for first time in ophthalmology in the beginning of the 20th century. Many studies have been conducted since 1990 for the delivery of many drugs in the eye (like steroids and so on). The first use of iontophoresis for riboflavin delivery was published recently for the treatment of keratoconus. For the moment, no veterinary clinical use of ionto has been described and no data for keratitis treatment is available.
  6. The aim of this study is to evaluate the clinical outcome after treatment of melting keratitis after iontophoresis of riboflavin and cross-linking in feline patients.
  7. Inclusion criteria were represented by feline patients presenting with corneal melting with poor response to previous medical treatment
  8. … and were selected on the presence of epithelial loss, cellular infiltration and stromal dissolution and a minimal corneal thickness of 300 µm.
  9. On day one, cats under general anesthesia have their cornea cleaned and sampled. Riboflavin impregnation by iontophoresis and an accelerated cross-linking.
  10. The iontophoresis device we have used has three parts : The corneal electrode is maintained on the corneal surface by suction and is filled with riboflavin till the grid is covered. The generator applies a constant current between the electrodes The return electrode which is connected to a needle inserted under the frontal skin.
  11. Follow-up was conducted for one month with evaluation of pain and clinical score and measurement of ulceration and infiltration surface.
  12. Clinical score was established by the evaluation on a scale ranging from 0 to 3 of six ocular signs, and pain score was established in the same way by presence or absence of pain symptoms.
  13. 6 cats were included in this study and presented with melting keratitis with an average duration time befor cross-linking treatment of 40 days. Two of them were Persians, One from 6 had a positive bacterial culture and 1/6 was positive for herpes virus.
  14. After treatment, we see a rapid reduction in pain and clinical score and disappearance of the ulcer and of the zone of infiltration. You see that there is a positive clinical score à one month, this is due to
  15. … the persistance of corneal vascularization which was mild in some cases, and moderate in others.
  16. The aim of this study was to evaluate the efficacy of cross-linking after iontophoresis of riboflavin. We have observed the resolution of corneal melting with complete epithelial healing and reduction of clinical and pain scores in all cases.
  17. If we compare to the results observed with conventional impregnation of riboflavin,
  18. … we see that all the criteria have a similar progression in both groups during the follow-up period.
  19. One of the question we can draw for this study is : what is the exact impregnation of riboflavin ? It is known in clear corneas that the diffusion of riboflavin is not the same with two different protocols. In the cases of keratitis, we don’t know what are the depth and concentration of riboflavin. We can just assume that it is enough to get a good clinical outcome.
  20. Adverse effects of iontophoresis have been described during the experimental phase with conditions which are very far from those we have used in this study. No adverse effect was observed.
  21. If we consider the duration of treatment, we see that conventional protocol takes more than an hour to be completed. With iontophoresis and accelerated cross-linking the duration of treatment can fall under 20 minutes according to the intensity of UVA you’re using. This has the advantage to shorten the duration of anesthesia.
  22. In a first step, we can conclude that iontophoresis of riboflavin followed by accelerated cross-linking was associated with a good outcome in the resolution of corneal melting in cats. That these results are similar to conventional instillation with a shorter treatment duration and no adverse reaction.
  23. But in second step, we can imagine that if iontophoresis could enhance penetration of riboflavin, this process could work for other therapeutic agents like antibiotics. There’s a big work to do in this field and this is another story…
  24. Thank you for your attention. I’ll be happy to answer to any question.